The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the ...

Ahead of the much-anticipated launch of Novo Nordisk’s blockbuster weight-loss drug Ozempic Wegovy in India, Dr. Reddy’s has ...

Dr Reddy's Laboratories' API plant in Telangana received two observations in a Form 483 during a recent inspection by the ...

Pharma major Dr Reddy's Laboratories delivered a muted operational performance in the fourth quarter of financial year ...

Dr. Reddy’s is focusing on a pipeline of complex drugs, including GLP-1 (such as Semaglutide) as well as biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug ...

The acquisition will cover all product formats ... Zacks Investment Research Image Source: Zacks Investment Research In consideration of the transaction, Dr. Reddy’s is liable to make an ...

(Image Courtesy: X/Dr Reddy's) Dr. Reddy’s has entered into ... second position among vaccines players in India. Through each product and partnership, our aim is to serve over 1.5 billion ...

Dr Reddy's Laboratories and FDC Ltd are recalling ... the bottle as the spike of the cap was lodged in the nozzle of the product bottle", the US health regulator stated. The company initiated ...

ANDAs, or Abbreviated New Drug Applications, is a regulatory submission to the FDA when seeking approval for a generic drug product. A current employee at Dr. Reddy's tells The Shreveport Bossier ...